Jupiter Neurosciences Announces 1-For-75 Reverse Stock Split, Effective Aug. 6
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurological and neurodegenerative
Jupiter Neurosciences is combining 75 old shares into 1 new share on August 6th—the company's shares stay the same value, just fewer of them. When a company does this, it often means the stock price was very low, so watch to see if the company's business gets stronger or if this was just a way to look better on paper.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.